Dendreon and Genentech to Collaborate on Trp-p8 Gene Platform

By Business Review Editor

Pharma Deals Review: Vol 2002 Issue 28 (Table of Contents)

Published: 2 Sep-2002

DOI: 10.3833/pdr.v2002.i28.1002     ISSN: 1756-7874

Section: Research & Development



Dendreon entered into a collaborative agreement with Genentech for the research, development and commercialization of monoclonal antibodies, small molecules and other products derived from Dendreon’s Trp-p8 gene platform...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details